NK cells mediate the anti-tumor effects of E1-deleted, type 5 adenovirus in a human tumor xenograft modelNIELSEN, L. L.Oncology reports. 2000, Vol 7, Num 1, pp 151-155, issn 1021-335XArticle

Sexism and Self-Healing in the UniversityNIELSEN, L. L.Harvard Educational Review Cambridge, Mass. 1979, Vol 49, Num 4, pp 467-474Article

Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer modelsNIELSEN, L. L; BIN SHI; MING LIU et al.Cancer research (Baltimore). 1999, Vol 59, Num 23, pp 5896-5901, issn 0008-5472Article

Evaluation of the wap-ras transgenic mouse as a model system for testing anticancer drugsNIELSEN, L. L; GURNANI, M; TYLER, R. D et al.Cancer research (Baltimore). 1992, Vol 52, Num 13, pp 3733-3738, issn 0008-5472Article

Mineralocorticoid concentrations in unstressed female rabbits and embryonic sodium transportNIELSEN, L. L; BENOS, D. J; BIGGERS, J. D et al.Journal of reproduction and fertility. 1987, Vol 81, Num 2, pp 553-562, issn 0022-4251Article

The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsiesGRACE, M. J; LEI XIE; NIELSEN, L. L et al.The American journal of pathology. 1999, Vol 155, Num 6, pp 1869-1878, issn 0002-9440Article

In wap-ras transgenic mice, tumor phenotype but not cyclophosphamide-sensitivity is affected by genetic backgroundNIELSEN, L. L; GURNANI, M; CATINO, J. J et al.Anticancer research. 1995, Vol 15, Num 2, pp 385-392, issn 0250-7005Article

Dose-response for glycaemic and metabolic changes 28 days after single injection of long-acting release exenatide in diabetic fatty Zucker ratsGEDULIN, B. R; SMITH, P; PRICKETT, K. S et al.Diabetologia (Berlin). 2005, Vol 48, Num 7, pp 1380-1385, issn 0012-186X, 6 p.Article

Effect of dietary fiber on the disposition and excretion of a food carcinogen (2-¹⁴C-labeled MeIQx) in ratsSJÖDIN, P; NYMAN, M; NIELSEN, L. L et al.Nutrition and cancer. 1992, Vol 17, Num 2, pp 139-151, issn 0163-5581Article

Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancerGURNANI, M; LIPARI, P; DELL, J et al.Cancer chemotherapy and pharmacology. 1999, Vol 44, Num 2, pp 143-151, issn 0344-5704Article

Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancerNIELSEN, L. L; LIPARI, P; DELL, J et al.Clinical cancer research. 1998, Vol 4, Num 4, pp 835-846, issn 1078-0432Article

Lung carcinoma and malignant mesothelioma in patients exposed to thorotrast : incidence, histology and p53 statusANDERSSON, M; WALLIN, H; JÖNSSON, M et al.International journal of cancer. 1995, Vol 63, Num 3, pp 330-336, issn 0020-7136Article

Drosophila alcohol dehydrogenase : a novel reporter gene for use in mammalian embryosNIELSEN, L. L; PEDERSEN, R. A.The Journal of experimental zoology. 1991, Vol 257, Num 1, pp 128-133, issn 0022-104X, 6 p.Article

Histopathology of salivary and mammary gland tumors in transgenic mice expressing a human Ha-ras oncogeneNIELSEN, L. L; DISCAFANI, C. M; GURNANI, M et al.Cancer research (Baltimore). 1991, Vol 51, Num 14, pp 3762-3767, issn 0008-5472, 6 p.Article

Induction of c-fos transcripts in early postimplantation mouse embryos by TGF-α, EGF, PDGF, and FGFNIELSEN, L. L; WERB, Z; PEDERSEN, R. A et al.Molecular reproduction and development (Print). 1991, Vol 29, Num 3, pp 227-237, issn 1040-452XArticle

Agents that increase phosphatidic acid inhibit the LH-induced testosterone productionLAURITZEN, L; NIELSEN, L.-L. A; VINGGAARD, A. M et al.Molecular and cellular endocrinology. 1994, Vol 104, Num 2, pp 229-235, issn 0303-7207Article

Exposure to measles in utero and Crohn's disease : Danish register studyNIELSEN, L. L. W; NIELSEN, N. M; MELBYE, M et al.BMJ. British medical journal (International ed.). 1998, Vol 316, Num 7126, pp 196-197, issn 0959-8146Article